ARCH will initiate clinical trials, announce data, and if positive, ARCH could easily be a $1 stock.
With no real standard of care it shouldn't be hard to produce a clinical benefit. This is a homerun investment.
Sentiment: Strong Buy
When is a tial expected to start? Thanks.